WELL Health Technologies Corp.
WHTCF
$3.75
-$0.066-1.73%
Weiss Ratings | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Reward Grade | C- | |||
Rating Factors | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.54 | |||
Price History | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -11.88% | |||
30-Day Total Return | -21.71% | |||
60-Day Total Return | -20.21% | |||
90-Day Total Return | 13.77% | |||
Year to Date Total Return | -23.47% | |||
1-Year Total Return | 24.42% | |||
2-Year Total Return | 12.49% | |||
3-Year Total Return | 13.98% | |||
5-Year Total Return | 217.21% | |||
52-Week High % Change | -25.47% | |||
52-Week Low % Change | 55.76% | |||
Price | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $5.12 | |||
52-Week Low Price | $2.45 | |||
52-Week Low Price (Date) | Sep 30, 2024 | |||
52-Week High Price (Date) | Dec 27, 2024 | |||
Valuation | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 932.34M | |||
Enterprise Value | 1.21B | |||
Price/Earnings (TTM) | 15.40 | |||
Earnings Per Share (TTM) | 0.25 | |||
Earnings Per Share Growth | -1,067.97% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.35 | |||
Price/Book (Q) | 1.51 | |||
Enterprise Value/Revenue (TTM) | 1.74 | |||
Price | $3.75 | |||
Enterprise Value/EBITDA (TTM) | 11.91 | |||
Enterprise Value/EBIT | 25.40 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 248.80M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | -- | |||
Address | 375 Water Street Vancouver, BC V6B 5C6 | |||
Website | well.company | |||
Country | Canada | |||
Year Founded | 2010 | |||
Profitability | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 6.84% | |||
Profit Margin | 7.63% | |||
Management Effectiveness | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 2.76% | |||
Return on Equity | 10.78% | |||
Income Statement | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 703.99M | |||
Total Revenue (TTM) | 703.99M | |||
Revenue Per Share | $2.83 | |||
Gross Profit (TTM) | 310.86M | |||
EBITDA (TTM) | 102.79M | |||
EBIT (TTM) | 48.20M | |||
Net Income (TTM) | 53.75M | |||
Net Income Avl. to Common (TTM) | 53.75M | |||
Total Revenue Growth (Q YOY) | 21.08% | |||
Earnings Growth (Q YOY) | -1,562.13% | |||
EPS Diluted (TTM) | 0.25 | |||
EPS Diluted Growth (Q YOY) | -916.39% | |||
Balance Sheet | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 48.97M | |||
Cash Per Share (Q) | $0.20 | |||
Total Current Assets (Q) | 233.12M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 679.54M | |||
Current Ratio (Q) | 1.136 | |||
Book Value Per Share (Q) | $2.52 | |||
Total Assets (Q) | 1.18B | |||
Total Current Liabilities (Q) | 205.16M | |||
Total Debt (Q) | 293.40M | |||
Total Liabilities (Q) | 499.72M | |||
Total Common Equity (Q) | 627.06M | |||
Cash Flow | WHTCF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -22.06M | |||
Cash from Financing (TTM) | -53.09M | |||
Net Change in Cash (TTM) | 17.78M | |||
Levered Free Cash Flow (TTM) | 103.63M | |||
Cash from Operations (TTM) | 93.08M | |||